Onderneming Jamjoom Pharmaceuticals Factory Company
Aandelen
4015
SA15QGU1UNH6
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
137 SAR | -2,14% | +3,79% | +19,13% |
09/05 | Tadawul-aandelen kelderen donderdag omdat de industriële productie van Saudi-Arabië in maart daalt | MT |
09/05 | Jamjoom Pharmaceuticals rapporteert hogere Q1 nettowinst, inkomsten | MT |
Vakgebied
Verkoop per activiteit
SAR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
86,9
%
| 797 | 87,0 % | 957 | 86,9 % | +19,98% |
Consumer Health Products
13,1
%
| 119 | 13,0 % | 144 | 13,1 % | +20,78% |
Verkoop per regio
SAR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Saudi Arabia
65,5
%
| 587 | 64,1 % | 721 | 65,5 % | +22,73% |
Gulf Cooperation Council
12,7
%
| 109 | 11,9 % | 140 | 12,7 % | +28,73% |
Iraq
9,6
%
| 91 | 9,9 % | 105 | 9,6 % | +15,34% |
North Africa and Other Export Markets
6,9
%
| 66 | 7,1 % | 76 | 6,9 % | +15,89% |
Egypt
5,4
%
| 64 | 7,0 % | 59 | 5,4 % | -7,69% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tarek Hosni
CEO | Chief Executive Officer | 60 | 15-05-21 |
Anwer Muhiddein
DFI | Director of Finance/CFO | 60 | 13-01-13 |
Mohammed Jamjoom
COO | Chief Operating Officer | 29 | 01-09-21 |
Hussam Salousa
PRN | Corporate Officer/Principal | 48 | 04-09-22 |
Mohammed Batarfi
HRO | Human Resources Officer | 40 | 01-02-22 |
Essam Al Sayed
SAM | Sales & Marketing | 57 | 14-10-21 |
Hisham Ahmed
SAM | Sales & Marketing | 57 | 01-07-21 |
Alaa Gamaleldin
PRN | Corporate Officer/Principal | 55 | 25-07-21 |
Wagih El Bokl
PRN | Corporate Officer/Principal | 56 | 10-07-21 |
Idrees Siddiqu
PRN | Corporate Officer/Principal | 57 | 01-03-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Faris AlGhannam
BRD | Director/Board Member | - | 19-06-22 |
Chairman | 64 | 19-06-22 | |
Founder | 39 | 19-06-22 | |
Director/Board Member | 96 | 19-06-22 | |
Director/Board Member | 63 | 19-06-22 | |
Director/Board Member | 41 | 19-06-22 | |
Director/Board Member | 79 | 19-06-22 | |
Director/Board Member | 44 | 19-06-22 | |
Director/Board Member | - | 19-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 70 000 000 | 21 000 000 ( 30,00 %) | 0 | 30,00 % |
Bedrijfsgegevens
Jamjoom Pharmaceuticals Factory Co.
Jeddah Industrial City Phase Five
21442, Jeddah
+
http://www.jamjoompharma.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,13% | 2,61 mld. | |
+19,62% | 43,27 mld. | |
+24,52% | 22,92 mld. | |
+20,29% | 15,43 mld. | |
+7,48% | 12,95 mld. | |
+42,51% | 11,83 mld. | |
-8,84% | 6,91 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+13,13% | 5,55 mld. |
- Beurs
- Aandelen
- Koers 4015
- Onderneming Jamjoom Pharmaceuticals Factory Company